Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
A baby boy in England was diagnosed with rare eye cancer at four weeks via newborn genetic screening, enabling early treatment and better vision outcomes.
Six-month-old Freddie Underhay of Birmingham was diagnosed with hereditary retinoblastoma, a rare eye cancer, at four weeks old through a national newborn genetic screening study in England.
The condition, caused by an RB1 gene mutation, was detected via whole genome sequencing of umbilical cord blood as part of the Generation Study, a research initiative by Genomics England and NHS England.
The early diagnosis, made without symptoms or family history, allowed prompt treatment with laser therapy and chemotherapy at Birmingham Children’s Hospital, significantly improving the chances of preserving his vision.
The study, now active at 51 hospitals, aims to screen up to 100,000 newborns for over 200 rare genetic conditions, with experts highlighting the potential for early intervention to transform outcomes.
Families like Freddie’s express deep gratitude, hoping the screening will become widely available.
Un bebé varón en Inglaterra fue diagnosticado con un raro cáncer de ojo a las cuatro semanas a través de la detección genética de recién nacidos, lo que permitió un tratamiento temprano y mejores resultados de visión.